The final Ocular Therapeutics Evening (OTE) of the University of Auckland’s Buchanan Ocular Therapeutics Unit (BOTU) series was held online and focused on paediatric eyecare.
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
US neuro-optometrist Dr Bryce Appelbaum's brain-based vision training model improved UK GP Dr Rangan Chatterjee's una
Digital: from $40/year +GST
Print + Digital: $110/year +GST (adds print magazine, wallplanner, delivery)
An optometrist recounts her experience on an Eyes4Everest outreach trip to Nepal's Annapurna region, providing eyecare at high-altitude
Veteran Auckland optometrist Trevor Skinner retires after nearly 50 years, known for his patient-first approach, empathy, and passion for optometry, having
Artificial intelligence (AI) use in eyecare is moving fast, but are regulation, ethics and real-world integration keeping pace? As clinicians and regulators grapple with how to harness its potential without compromising patient safety or equity, Drew Jones examines where AI use in eyecare stands and
February is my favourite time of the year. Not only is there beautiful summer weather and warm seawater, but this is the time when the Australian and New Zealand Glaucoma Society (ANZGS) Congress takes place! This year’s meeting was in Sydney CBD’s Masonic Centre. It’s a fabulous venue with beautifu
Patients with glaucoma are at high risk for developing dry eye disease (DED)1, with 40–59% of patients with glaucoma being diagnosed with DED worldwide2. DED in glaucoma is multifactorial and can be